logo BDSP

Base documentaire


Votre avis nous intéresse

Le réseau BDSP met en oeuvre un projet d'innovation et d'amélioration de ses services, dans le souci constant de proposer des contenus de qualité adaptés aux besoins des utilisateurs.

Identifier de nouvelles sources de financements est la condition nécessaire pour assurer la poursuite et la pérennité de cet outil unique qu'est la BDSP, tout en le faisant évoluer.

Pour définir un nouveau modèle économique, nous avons besoin de votre avis : merci de répondre à notre enquête (temps estimé : 5 minutes).

Participer maintenant
Participer plus tard J'ai déjà participé

  1. The Cost-Effectiveness of Nationwide Breast Carcinoma Screening in Finland, 1987-1992.

    Article - En anglais

    BACKGROUND

    The aim of this study was to evaluate the cost-effectiveness, from a societal perspective, of the Finnish nationwide breast carcinoma screening program.

    METHODS

    The effects were measured in life-years saved from 1987 to 2020, using data from the nationwide program to the end of 1992.

    A total of 90,000 women ages 50-59 were invited for screening during the years 1987-89.

    The total number of participants screened was 76,000.

    The screening interval was 24 months, with follow-up to the end of 1992.

    From the beginning of 1993, the estimation model used parameters based on published studies and national cancer statistics.

    Data on health care and non-health care costs and time costs were obtained from internal accounts of screening units, published studies, national statistics, health market sources, and a questionnaire completed by a sample of 1400 screening attendees.

    The discount rate, the annual rate of time preference over future costs and life-years saved, was 3%. The main outcome measure was the cost per life-year saved.

    RESULTS

    The estimated number of life-years of life saved was 578, of which 8% occurred 1987-1992.

    The estimated life-years saved per 1000 screenings was 3.2. The total costs were $11 million in U.S. dollars, i.e., $14.3 million per 100,000 participants. (...)

    Mots-clés Pascal : Carcinome, Glande mammaire, Dépistage, Mammographie, Analyse coût efficacité, Economie santé, Finlande, Europe, Homme, Tumeur maligne, Glande mammaire pathologie, Radiodiagnostic

    Mots-clés Pascal anglais : Carcinoma, Mammary gland, Medical screening, Mammography, Cost efficiency analysis, Health economy, Finland, Europe, Human, Malignant tumor, Mammary gland diseases, Radiodiagnosis

    Logo du centre Notice produite par :
    Inist-CNRS - Institut de l'Information Scientifique et Technique

    Cote : 99-0419807

    Code Inist : 002B20E02. Création : 22/03/2000.